THBS1 and pancreatic neoplasm: Yet, in the first clinical validation we observed significantly lower THBS1 expression in PDAC cases relative to controls [33], and this phenomenon has been reported in pancreatic cancer patients up to 24 months prior to diagnosis [27,41].